Organization
27
Full-time team members (jul 2026)
5 areas: Executive & Operations · Sales · Product & Medical · Technology & Data Science · Marketing
Org Chart
CEOExecutive & OperationsProduct & MedicalTechnology & Data ScienceSalesMarketing
Departments
Exec & Operations
7
CEO, COO, CMO, HR, EA, Accounting, Legal
Product & Medical
8
Medical DS, QA, CS, PM, Clinical Research
Technology & DS
4
CTO, ML Ops, Analytics, Frontend
Sales
6
Sales mgr, BD, life science, UK, SDR
Marketing
2
Lead strategy and content
Commercial engine
Since the Seed round, the commercial function has been built into a structured go-to-market team, led by Giuseppe Razzani (BD Director, who ran a €3.5M ARR portfolio at DocPlanner). This is a functional view of the go-to-market motion, so some members also appear under other departments above.
Business development
Agustín Oyhamburu · Jorge Juan · Irene González (Life Science)
Pipeline generation (SDR)
Natasha Rodrigues
UK expansion
Christopher McKee (UK Sales Director, PhD melanoma)
Lead strategy & marketing
María Ribagorda · Pablo Cánovas (content)
Customer success
Jon Roca
Project mgmt & sales support
Alba Rodriguez (PM Lead) · José Luis Hernández
Hiring plan
The team scales in two sequenced waves: a first wave (resourced by the capital already secured) that builds toward €1M ARR, and a Series A wave that funds US expansion and scale once €1M ARR is reached.
First wave (now to €1M ARR)
Builds the delivery, medical and commercial capacity to reach the €1M ARR milestone. 6 hires.
2
Customer Success
NRR expansion across the hospital and insurance base: onboarding, adoption, additional modules
1
Project Manager for Life Science
Delivery and coordination of pharma clinical-research studies and trial deployments
1
Medical Data Scientist
Expand algorithm, severity and prediction capabilities
1
Clinical Affairs Manager
Clinical evidence and FDA pre-submission preparation, alongside Saray (RA/QA, BSI-trained)
1
Business Development
Convert open pipeline into pharma frames and insurance deals
Series A wave (post-€1M · US expansion and scale)
Funded by the Series A, once the €1M ARR milestone opens the round.
1
VP Sales US
Activate the US commercial pipeline post-FDA
2
1-2 senior commercial hires
Expand pharma and insurer channels at scale
3
2-3 ML engineers / data scientists
Scale prediction & phenotyping capabilities and throughput
4
Marketing / Growth lead
Scale demand generation and category leadership beyond the current two-person marketing team
5
US Market Access / Reimbursement
Payer relations, reimbursement pathways and coding for the US launch, post-FDA
6
Project Manager
Scale deployment and delivery capacity as US and enterprise accounts grow
No C-suite changes
No C-suite changes are planned through the Series A.